Bellicum Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Bellicum Pharmaceuticals is reported as 0.0015 billion Dollars in the fiscal year 2022. The earnings were -0.81 Dollars per share in 2022, which was 96.63 higher than 2019. And about -2.0E-5 billion Dollars are reported as free cash flow in the financials of Bellicum Pharmaceuticals 2022. No dividends were paid to the shareholders of the Bellicum Pharmaceuticals stock OTCPK:BLCM in the financial year 2022.

$1.50M

Revenue

$-0.81

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

1.50

Earnings Per Share

-0.81

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	$1.50M	$2.14M	$1.12M	$0.19M	$0.39M	$0.28M	$1.78M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.73	$-0.81	$-24.01	$-24.40	$-28.38	$-25.70	$-18.40	$-71.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	9.05M	5.05M	4.43M	3.33M	2.72M	2.7M	2.64M
OCF	Operating Cash Flow	N/A	$0.00M	$-77.57M	$0.00M	$0.00M	$-50.44M	$-35.73M	$-57.31M
FCF	Free Cash Flow	N/A	$0.00M	$-78.09M	$-76.40M	$-85.12M	$-57.66M	$-41.15M	$-58.11M
FCFS	Free Cash Flow Per Share	$-0.74	$-0.84	$-16.67	$-18.99	$-26.84	$-21.39	$-15.62	$-,232.24

Bellicum Pharmaceuticals financials at a glance

Financials

Discover